S. Wagner

I. Wistuba, R. Bueno, A. Gutin, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Adjuvant therapy of renal cell carcinoma with active-specific-immunotherapy (ASI) using autologous tumor vaccine.

S. Wagner, A. Richter, R. Repmann, 1997, Anticancer research.

Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition

O. Olopade, K. Offit, D. Pruss, 2022, JCO precision oncology.

A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree

M. Skolnick, S. Hunt, P. Hopkins, 2004, Human Genetics.

Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing

J. Lancaster, C. Adami, A. Gutin, 2021, JCO precision oncology.

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer

J. Lancaster, W. Gradishar, A. Gutin, 2020, Annals of Surgical Oncology.

Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators.

E. Rakha, J. Lanchbury, M. Pajares, 2015, European journal of cancer.

Explorer Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinoma

I. Wistuba, R. Bueno, A. Gutin, 2017 .

Development and validation of a residual risk score to predict breast cancer risk in unaffected women negative for mutations on a multi-gene hereditary cancer panel.

A. Gutin, J. Lanchbury, R. Wenstrup, 2017 .

Abstract P3-07-02: Prognostic and predictive relevance of HER2 status in ductal carcinomain situ: Results from the UK/ANZ DCIS trial

J. Cuzick, J. Forbes, I. Fentiman, 2016 .

Imaging , Diagnosis , Prognosis Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma

Edward S. Kim, I. Wistuba, S. Swisher, 2013 .

The landscape of genomic alterations across childhood cancers

Michael C. Heinold, Jules N. A. Kerssemakers, David C. Jones, 2018, Nature.

Performance of the IBIS/Tyrer-Cuzick (TC) Model by race/ethnicity in the Women’s Health Initiative.

Jennifer L. Caswell-Jin, J. Manson, A. Gutin, 2020 .

Characterisation of seven medications approved for attention-deficit/hyperactivity disorder using in vitro models of hepatic metabolism

M. DelBello, J. Frazier, J. Lanchbury, 2022, Xenobiotica; the fate of foreign compounds in biological systems.

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.

J. Cuzick, D. Berney, P. Scardino, 2011, The Lancet. Oncology.

Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinoma.

A. Gutin, J. Reid, M. B. Warf, 2015, Biomarkers in medicine.

Ancestrally unbiased polygenic breast cancer (BC) risk assessment.

O. Olopade, A. Gutin, T. Slavin, 2021 .

[L-2-hydroxyglutaric aciduria: report on two cases].

S. Wagner, G. Salomons, E. Schmitt, 2014, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Prediction of distant recurrence in resected stage I and II lung adenocarcinoma.

J. Lanchbury, S. Bettelli, A. Maiorana, 2016, Lung cancer.